Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Distinguished William and Mary Professor Joins Luna Innovations

Abstract:
Dr. Brian Holloway Named Director of Contract Research for nanoWorks Division in Danville

Distinguished William and Mary Professor Joins Luna Innovations

Danville, VA | Posted on August 16, 2006

Brian Holloway, Ph.D., has recently joined Luna’s nanoWorks division as Director of Contract Research. Dr. Holloway is formerly a tenured associate professor in the Department of Applied Science at The College of William and Mary, where his research group patented carbon nanosheets, a new two-dimensional nanostructure of carbon that has potential uses in sensors, fuel cells, batteries and medical devices. His group authored more than 10 papers on the nanosheets, including one that appeared in The Journal of Chemical Physics (issue May 21, 2006), a publication of the American Institute of Physics.

Throughout his career, Dr. Holloway has been actively involved in developing faster and cheaper ways to produce carbon nanotubes. In collaboration with the NASA’s Langley Research Center, his team used Jefferson Lab's (the U.S. Department of Energy’s national laboratory for nuclear physics research) Free-Electron Laser to explore the fundamental science of how and why nanotubes form.

With three patents related to nanotechnology, Dr. Holloway specializes in the synthesis of new materials and characterization of thin films, surfaces and interfaces. He has been a principal investigator on more than $8.2 million of externally funded research projects. In 2006, Dr. Holloway was named the William and Mary Art and Sciences Distinguished Associate Professor.

He earned a master’s degree and doctorate in Mechanical Engineering from Stanford University, and received a bachelor’s degree from the University of Florida.

Dr. Holloway compliments the senior management team at Luna’s nanoWorks Division, which includes:

Robert P. Lenk, Ph.D., President – Dr. Lenk is the founder of three companies, has been involved with two initial public offerings, and is experienced in bringing new pharmaceuticals to market. He has served as President of Oncovector Inc., a biopharmaceutical company and is also a former President and Chief Executive Officer of Therapeutics 2000, an inhalation pharmaceutical research company. Dr. Lenk holds a doctorate in Cell Biology from the Massachusetts Institute of Technology.

Stephen R. Wilson, Ph.D., Chief Scientific Officer – Dr. Wilson is a pioneer in fullerene chemistry and a founder and former Chief Scientific Officer of one of the first pharmaceutical companies specializing in creating therapeutics from fullerene technology. He is also a founder and former Director of the Center for Advanced Materials and Nanotechnology at New York University. Dr Wilson holds 16 patents and received his bachelor’s, master’s and doctoral degrees from Rice University.

Kenneth L. Walker, Ph.D., Executive Vice President – Dr. Walker is a founder and former President of Specialty Photonic Devices, a business unit of OFS Fitel which focused on the development of proprietary materials and which was purchased from Lucent Technologies, Inc. He is also a former head of optical fiber research at Bell Laboratories. Dr. Walker received a bachelor’s degree from the California Institute of Technology and a doctorate from Stanford University. He is a member of the National Academy of Engineers and holds more than 50 patents.

####

About Luna nanoWorks:
Luna nanoWorks is a division of Luna Innovations Incorporated. Luna nanoWorks is developing products empowered by nanomaterials, with an initial application focused on medical imaging. The company also manufactures high-quality carbon nanomaterials, including single-walled carbon nanotubes (SWCNT) and proprietary TRIMETASPHERE™ carbon nanomaterials.

For more information, please click here.

Contact:
Karin Clark
Director of Marketing & Communications
kclark@lunainnovations.com

Copyright © Luna nanoWorks

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Materials/Metamaterials/Magnetoresistance

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024

Catalytic combo converts CO2 to solid carbon nanofibers: Tandem electrocatalytic-thermocatalytic conversion could help offset emissions of potent greenhouse gas by locking carbon away in a useful material January 12th, 2024

Announcements

NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024

Innovative sensing platform unlocks ultrahigh sensitivity in conventional sensors: Lan Yang and her team have developed new plug-and-play hardware to dramatically enhance the sensitivity of optical sensors April 5th, 2024

Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024

A simple, inexpensive way to make carbon atoms bind together: A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules, which are critical for drug development April 5th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project